Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

John H. Weston Jr. Releases Free
Healthcare & PharmaceuticalCompany Update

John H. Weston Jr. Releases Free "Early Warning Signs" Checklist to Help Prevent Behavioral Crises

May 15, 2026 10:50 AM

John H. Weston Jr. today announced the release of a free behavioral support resource titled the "15-Minute Early Warning Signs Checklist." The tool is designed for families, caregivers, support staff, educators, and everyday individuals who want a simple way to identify stress patterns before they turn into behavioral crises.The checklist focuses on practical observation, predictable routines, and early intervention. It was built around the same...

Read more
CVS Health’s Annual Impact in Rhode Island
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health’s Annual Impact in Rhode Island

May 15, 2026 9:00 AM

With more than 9,000 locations and 300,000 employees, CVS Health is a driving force in the American economy, delivering $474 billion in economic impact nationwide.As one of the country's largest private employers, we're making health care more affordable and accessible for you and your family.Discover how our economic footprint benefits communities across the U.S: creating jobs, fueling local investments and generating tax revenue that supports...

Read more
EHDS Readiness Shifts from EU Policy to Provider Budget and Vendor Accountability
Healthcare & PharmaceuticalConferences

EHDS Readiness Shifts from EU Policy to Provider Budget and Vendor Accountability

May 15, 2026 8:55 AM

Black Book Research today released pre-HIMSS26 Europe findings from a 14-country study of 881 healthcare technology, finance, clinical informatics, procurement, and data governance leaders, concluding that European Health Data Space readiness is no longer primarily a Brussels policy debate. It is now a provider execution test involving funding, vendor commitments, EHR readiness, data quality, and secondary-use operations.The study, conducted...

Read more
NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering
Healthcare & PharmaceuticalFinancing

NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering

May 15, 2026 8:35 AM

NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses and their variants cannot escape, today announced it has entered into a securities purchase agreement with a single fundamental institutional investor for the purchase and sale of 1,333,334 million common shares (or...

Read more
NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II
Healthcare & PharmaceuticalEarnings

NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II

May 15, 2026 8:00 AM

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2026 with the Securities and Exchange Commission (SEC) on Thursday, May 14, 2026. The report can be accessed at the SEC website by searching for the Company (https://www.sec.gov/edgar/browse/?CIK=1379006&owner=exclude) .Clinical Stage NV-387, a Single Drug, Meets Many Unmet Medical Needs in...

Read more
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results
Healthcare & PharmaceuticalEarnings

CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results

May 14, 2026 4:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2026.First Quarter 2026 and Recent Financial and Operating HighlightsGenerated revenue of $3.2 million for the first quarter 2026 compared to $3.6 million for...

Read more
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program
Healthcare & PharmaceuticalCompany Update

Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitoring Program

May 14, 2026 3:05 PM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced that it has executed a non-binding letter of intent ("LOI") to acquire WellCare Today. The proposed transaction structure includes a structured cash payment of $3 million, with the balance to be satisfied through a performance-based earnout issued in preferred stock.WellCare Today is a...

Read more
CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday
Healthcare & PharmaceuticalCompany Update

CMS Hemp Program Insiders Admit Bypassing FDA Safety Standards for a Potential $34.5 Billion Medicare Payday

May 14, 2026 2:00 PM

As a federal judge prepares to rule on the legality of the Centers for Medicare & Medicaid Services' (CMS) cannabinoid access program, newly surfaced public statements from industry participants are intensifying scrutiny surrounding the entire initiative. At issue is the CMS Substance Access Beneficiary Engagement Incentive (BEI) program, currently under review in:Smart Approaches to Marijuana et al. v. Robert F. Kennedy Jr. et al.Case No....

Read more
ALYZE Prepares to Open Utah's First Facility Where Your Gym, Doctor, Lab, and Recovery are All Under One Roof
Healthcare & PharmaceuticalCompany Update

ALYZE Prepares to Open Utah's First Facility Where Your Gym, Doctor, Lab, and Recovery are All Under One Roof

May 14, 2026 2:00 PM

Most health-conscious professionals are managing their wellbeing across five different locations. A gym that has never seen the bloodwork. A hormone specialist who has no idea what the fitness plan looks like. A recovery studio operating completely independently from the functional medicine doctor on the other side of town. A lab that sends results into a void with no one to interpret them in the context of everything else. ALYZE was built...

Read more
Hippocratic Cancer Research Foundation Announces Two Signature Chicago Fundraising Events:
Healthcare & PharmaceuticalCompany Update

Hippocratic Cancer Research Foundation Announces Two Signature Chicago Fundraising Events: "Sail and Soiree" Fashion Show and "Golden Hour for Good" Rooftop Party

May 14, 2026 1:55 PM

The Hippocratic Cancer Research Foundation, a Chicago-based 501(c)(3) nonprofit dedicated to advancing cancer research, today announced two signature fundraising events taking place in Chicago during the week of June 18, 2026: the HCRF Annual Fashion Show, "Sail and Soiree," and "Golden Hour for Good," the HCRF Young Professionals Board rooftop party.Event details, tickets, and sponsorship information are available for both June 2026...

Read more
The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Reality Check
Healthcare & PharmaceuticalProduct Announcements

The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Reality Check

May 14, 2026 11:00 AM

Black Book Research today released findings from The Data-Ready Hospital: Europe's EHR Vendors Face the Data Valorisation Test, a European provider survey evaluating how electronic health record vendors help healthcare organizations convert clinical information into trusted, governed, interoperable and actionable data.The 2026 study surveyed 662 healthcare IT leaders and EHR users across eight major European EMR adoption markets: the United...

Read more
Desert Oasis Healthcare's
Healthcare & PharmaceuticalAwards

Desert Oasis Healthcare's "The Pulse" TV Show Wins Platinum Viddy Award for Alzheimer's Episode

May 14, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) has received a Platinum Viddy Award for its Season 2 episode of The Pulse titled "Loving Someone Who No Longer Knows You: The Reality of Alzheimer's", hosted by Emmy Award-winning Journalist Bianca Rae. The episode explored the emotional realities faced by patients, caregivers, and families navigating Alzheimer's disease. Through personal storytelling, expert insight, and compassionate reporting, the episode aimed...

Read more
NCQA Receives Grant from the Helmsley Charitable Trust to Advance High-Quality Diabetes Care
Healthcare & PharmaceuticalAwards

NCQA Receives Grant from the Helmsley Charitable Trust to Advance High-Quality Diabetes Care

May 14, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) is proud to announce new funding from The Leona M. and Harry B. Helmsley Charitable Trust to strengthen clinician and health plan accountability for delivering high‑quality diabetes care. The three‑year initiative will advance quality of care for people living with type 1 and type 2 diabetes through developing new HEDIS®[1] diabetes measures, innovating approaches that capture clinical...

Read more
Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program
Healthcare & PharmaceuticalFinancing

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 14, 2026 9:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that, through its wholly owned subsidiary Cana Laboratories, it is pursuing a strategic research and development (R&D) financing program with the European Investment Bank (EIB), the financing arm of the European Union and one of the world's largest multilateral lenders.In connection with this...

Read more
Dr. Anurag Agarwal Shares Insights on Improving Outcomes with Revision Facelift Surgery
Healthcare & PharmaceuticalCompany Update

Dr. Anurag Agarwal Shares Insights on Improving Outcomes with Revision Facelift Surgery

May 14, 2026 9:00 AM

Dr. Anurag Agarwal, double board-certified facial plastic surgeon and medical director of Aesthetic Surgery Center in Naples, FL, is sharing clinical insights on revision facelift surgery, a subspecialty that requires a different level of surgical planning than a primary procedure. Revision cases involve working within tissue that has already been surgically altered, which means the anatomy, scarring, and structural support differ from patient...

Read more
CVS Health: All Rhode Island CVS Pharmacy(R) Locations Now Accept WIC for Infant Formula
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health: All Rhode Island CVS Pharmacy(R) Locations Now Accept WIC for Infant Formula

May 14, 2026 9:00 AM

CVS Pharmacy® (NYSE:CVS) announced that all 56 locations in Rhode Island are now authorized to accept the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) for infant formula purchases, marking the first time all CVS Pharmacy stores in any state are approved for the program.This statewide authorization reflects CVS Pharmacy's ongoing commitment to meeting customers where they are, reinforcing the company's focus on...

Read more
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
Healthcare & PharmaceuticalCompany Update

MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2

May 14, 2026 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), today announced positive unblinded results from its completed Phase 1 clinical trial evaluating Ketamir-2, the Company's proprietary selective oral NMDA receptor modulator.The randomized, double-blind, placebo-controlled Phase 1 study evaluated the safety, tolerability, and pharmacokinetics of orally administered Ketamir-2 in healthy volunteers across single ascending dose (SAD)...

Read more
Praia Health Joins the Microsoft for Startups Pegasus Program to Accelerate Innovation and Growth
Healthcare & PharmaceuticalPartnerships

Praia Health Joins the Microsoft for Startups Pegasus Program to Accelerate Innovation and Growth

May 14, 2026 8:00 AM

Praia Health, a leading innovator in patient experience orchestration for health systems, is excited to announce our acceptance into the Microsoft for Startups Pegasus Program. This collaboration provides Praia with access to powerful AI tools, Microsoft Azure credits, and a global customer network to help scale faster and smarter.For health systems, the timing couldn't be more urgent. Patients today expect consumer-grade digital experiences,...

Read more
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
Healthcare & PharmaceuticalEarnings

CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress

May 14, 2026 8:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update highlighting the Company's ongoing strategic transformation and execution progress.The first quarter of 2026 marked the beginning of a significant...

Read more
Israel's Digital Health Stress Test: AI, Cybersecurity, and Wartime Care Redefine the 2026 Healthcare IT Market
Healthcare & PharmaceuticalCompany Update

Israel's Digital Health Stress Test: AI, Cybersecurity, and Wartime Care Redefine the 2026 Healthcare IT Market

May 14, 2026 7:10 AM

Black Book Research today announced the release of State of Digital Healthcare IT 2026: Israel, a new market intelligence report examining one of the world's most digitally advanced and operationally pressured healthcare IT environments.The report finds that Israel is no longer a first-wave digitization market. Core electronic medical records, HMO-based longitudinal patient data, digital patient portals, national health information exchange,...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?